ARTICLE | Company News
Fournier discloses marketing deals
October 8, 2004 7:00 AM UTC
Laboratoires Fournier (Dijon, France) said its Fournier Pharma division received a license from Recordati (Milan, Italy) to market its Zanidip lercanidipine oral calcium-channel blocker to treat hypertension in Indonesia, Vietnam and other Asian countries. ...